ROBERT FRANK: Open Payments
NPI 1447666870 · BRANDON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 42 payments from 12 companies in 2025. Trend: 2023 $797 · 2024 $1,105 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $360 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $229 |
| Otsuka America Pharmaceutical, Inc. | 9 | $165 |
| Neurocrine BioSciences, Inc. | 4 | $79 |
| Alkermes, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Lundbeck LLC | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, Auvelity, COBENFY, LYBALVI.
Industry payments across WI — which companies pay providers there.
